Literature DB >> 3955111

Acute and chronic effects of haloperidol on plasma and brain homovanillic acid in the rat.

W H Chang, E K Yeh, W H Hu, Y T Tseng, M C Chung, H F Chang.   

Abstract

The effects of acute and chronic administration of haloperidol on homovanillic acid (HVA) in plasma and the brain were examined in the rat. Acute haloperidol treatment (1 mg/kg) resulted in highly significant elevations in HVA within 30 min and produced a maximal increase of HVA in 3-6 hr in both plasma and the whole brain. The response of brain HVA to increasing doses (0.05-30 mg/kg) of haloperidol showed an inverted U pattern. Plasma HVA showed a very flat response to lower doses (less than or equal to 5 mg/kg) of haloperidol and a dramatically elevated one to higher doses (greater than or equal to 10 mg/kg). Haloperidol produced a parallel increase in plasma and brain HVA at lower doses (less than or equal to 2 mg/kg) only. After chronic administration of haloperidol for up to 28 days, the response of HVA in plasma correlated mainly with, but tolerated later than, those in the whole brain and the olfactory tubercle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955111     DOI: 10.1016/0006-3223(86)90165-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  7 in total

1.  Dose-response curves of homovanillic acid in pre-frontal cortex and caudate following antipsychotic drugs: relation to clinical potencies.

Authors:  W H Chang; T Y Chen; H S Wu; W H Hu; E K Yeh
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

3.  Time-response curves of homovanillic acid in caudate and pre-frontal cortex following acute neuroleptic administration.

Authors:  W H Chang; T Y Chen; E K Yeh
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.

Authors:  J G Csernansky; E P Bellows; D E Barnes; L Lombrozo
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test.

Authors:  Mercedes Zumárraga; Miguel A González-Torres; Aurora Arrue; Ricardo Dávila; Wendy Dávila; Lucía Inchausti; Lucía Pérez-Cabeza; Aránzazu Fernández-Rivas; Sonia Bustamante; Nieves Basterreche; José Guimón
Journal:  Neurochem Res       Date:  2011-04-08       Impact factor: 3.996

6.  Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in guinea pigs.

Authors:  W H Chang; S S Jaw; H S Wu; L Tsay; E K Yeh
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Sansoninto attenuates aggressive behavior and increases levels of homovanillic acid, a dopamine metabolite, in social isolation-reared mice.

Authors:  Takuya Watanabe; Hikari Iba; Hiroshi Moriyama; Kaori Kubota; Shutaro Katsurabayashi; Katsunori Iwasaki
Journal:  J Tradit Complement Med       Date:  2021-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.